Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
University of Cambridge
Headquarters: Cambridge, United Kingdom
Website: http://www.cam.ac.uk
Year Founded: 1209
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Mar 7, 2025
Finance
Strategics back Trimtech’s protein cluster degraders with $31M: Finance Report
Pharma venture arms join founding investors CIC, DDF to back U.K. start-up; plus venture rounds for Garuda, Ataraxis and Callio, and Tenaya’s follow-on
BioCentury | Feb 15, 2025
Discovery & Translation
Science Spotlight: Using HIV to help allogeneic CAR T cells evade immune attack
BioCentury’s roundup of translational innovations also includes a human hypothalamus atlas from Novo and collaborators, and four papers with links to newcos
BioCentury | Jan 15, 2025
Emerging Company Profile
Mursla: Using extracellular vesicles to detect cancer
Led by former banker Pierre Arsène, the start-up’s first goal is surveillance of cirrhosis patients at risk of liver cancer
BioCentury | Dec 5, 2024
Management Tracks
Várhelyi to lead health at EU
Plus updates from Nouscom, Eton, Healx, Medipost, Fairjourney, Italfarmaco and Cellino
BioCentury | Nov 20, 2024
Discovery & Translation
Science Spotlight: A new obesity target may avoid nausea, muscle loss
BioCentury’s roundup of translational innovation: Embark/Novo discover new obesity target, Canbridge delivers large DMD gene, and more
BioCentury | Sep 19, 2024
Discovery & Translation
Science Spotlight: Cancer prognosis via deep learning, new protein degraders, and more
BioCentury’s roundup of translational innovations
BioCentury | Jun 21, 2024
Discovery & Translation
Science Spotlight: Obesity, GLP-1R influence immune checkpoints; and more
BioCentury’s roundup of translational innovations
BioCentury | Jun 21, 2024
Finance
Venture Report: Syncona’s backs a pair of biotechs; Marea makes debut with $190M
Plus: Forbion’s new sustainability fund, and rounds for Elion, ashibio, NephroDI and Ability
BioCentury | Mar 16, 2024
Discovery & Translation
Science spotlight: Boosting immunotherapy by counteracting Tregs in tumor-draining lymph nodes and more
BioCentury’s roundup of translational innovations
BioCentury | Feb 29, 2024
Discovery & Translation
Science spotlight: SOX9 switch for kidney regeneration, improved base editors and more
BioCentury’s roundup of translational innovations
Items per page:
1 - 10 of 313